|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 76, 16-23, Copyright © 1978 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
DJ Hearse, DA Stewart and MV Braimbridge
Cardioplegic protective infusates are designed to induce rapid diastolic
arrest and also to reduce or delay the onset of ischemic damage. As this
study shows, the use of such infusates can greatly improve postischemic
recovery of cardiac function. A number of investigators include glucose,
insulin, or mannitol in their infusates in an attempt to increase the
amount of protection afforded to the ischemic myocardium. Using an
isolated, working rat heart model of cardiopulmonary bypass and ischemic
cardiac arrest, we have shown that under certain conditions these additives
can be deterimental to tissue protection. The deleterious effects of
glucose and mannitol are dose dependent and can be modified by the
inclusion of insulin in the infusate. The damaging effects of glucose
appear to be both osmotic and metabolic in origin and those of mannitol,
purely osmotic. The effects of insulin are complex and may affect a number
of cellular processes.
ARTICLES
Myocardial protection during ischemic cardiac arrest. Possible deleterious effects of glucose and mannitol in coronary infusates
This article has been cited by other articles:
![]() |
M. T. Dirksen, G. J. Laarman, M. L. Simoons, and D. J.G.M. Duncker Reperfusion injury in humans: A review of clinical trials on reperfusion injury inhibitory strategies Cardiovasc Res, June 1, 2007; 74(3): 343 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Dobson and M. W. Jones Adenosine and lidocaine: a new concept in nondepolarizing surgical myocardial arrest, protection, and preservation J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 794 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kennergren, V. Mantovani, L. Strindberg, E. Berglin, A. Hamberger, and P. Lonnroth Myocardial interstitial glucose and lactate before, during, and after cardioplegic heart arrest Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E788 - E794. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Lazar The Insulin Cardioplegia Trial J. Thorac. Cardiovasc. Surg., May 1, 2002; 123(5): 842 - 844. [Full Text] [PDF] |
||||
![]() |
H. L. Lazar, S. Chipkin, G. Philippides, Y. Bao, and C. Apstein Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations Ann. Thorac. Surg., July 1, 2000; 70(1): 145 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nakamura, H. Kuroda, N. Takemoto, S. Ohgi, and T. Mori Risk of low calcium and high magnesium in continuous warm hyperkalemic cardioplegia Ann. Thorac. Surg., October 1, 1999; 68(4): 1295 - 1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Rao, F. Merante, R. D. Weisel, T. Shirai, J. S. Ikonomidis, G. Cohen, L. C. Tumiati, N. Shiono, R.-K. Li, D. A. Mickle, et al. Insulin stimulates pyruvate dehydrogenase and protects humanventricular cardiomyocytes from simulated ischemia J. Thorac. Cardiovasc. Surg., September 1, 1998; 116(3): 485 - 489. [Abstract] [Full Text] |
||||
![]() |
X.-H. Ning, Keith.F. Childs, and S. F. Bolling Glucose Level and Myocardial Recovery After Warm Arrest Ann. Thorac. Surg., December 1, 1996; 62(6): 1825 - 1829. [Abstract] [Full Text] |
||||
![]() |
H. L. Lazar, X. Zhang, S. Rivers, S. Bernard, and R. J. Shemin Limiting Ischemic Myocardial Damage Using Glucose-Insulin-Potassium Solutions Ann. Thorac. Surg., August 1, 1995; 60(2): 411 - 416. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |